Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Current Liabilities: 2015-2025

Historic Total Current Liabilities for AC Immune (ACIU) over the last 11 years, with Sep 2025 value amounting to $122.9 million.

  • AC Immune's Total Current Liabilities rose 5.41% to $122.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.9 million, marking a year-over-year increase of 5.41%. This contributed to the annual value of $122.9 million for FY2025, which is N/A change from last year.
  • Latest data reveals that AC Immune reported Total Current Liabilities of $122.9 million as of FY2025, which was up 106,638.00% from $115,109 recorded in FY2024.
  • In the past 5 years, AC Immune's Total Current Liabilities registered a high of $122.9 million during FY2025, and its lowest value of $15,305 during FY2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $115,109 (2024), whereas its average is $41.0 million.
  • In the last 5 years, AC Immune's Total Current Liabilities slumped by 99.87% in 2023 and then surged by 652.10% in 2024.
  • Over the past 5 years, AC Immune's Total Current Liabilities (Yearly) stood at $21.9 million in 2021, then slumped by 45.62% to $11.9 million in 2022, then slumped by 99.87% to $15,305 in 2023, then soared by 652.10% to $115,109 in 2024, then reached $122.9 million in 2025.